Fennec Pharmaceuticals Inc. (FENC)
NASDAQ: FENC · Real-Time Price · USD
8.75
+0.01 (0.17%)
At close: Jul 24, 2025, 4:00 PM
8.72
-0.02 (-0.29%)
After-hours: Jul 24, 2025, 4:04 PM EDT
Fennec Pharmaceuticals Employees
Fennec Pharmaceuticals had 32 employees as of December 31, 2024. The number of employees increased by 3 or 10.34% compared to the previous year.
Employees
32
Change (1Y)
3
Growth (1Y)
10.34%
Revenue / Employee
$966,000
Profits / Employee
-$451,188
Market Cap
241.53M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
FENC News
- 7 weeks ago - Fennec Announces Results of Annual Meeting - GlobeNewsWire
- 2 months ago - Fennec Pharmaceuticals Inc. (FENC) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Fennec Pharmaceuticals to Report First Quarter 2025 Financial Results on May 13, 2025 - GlobeNewsWire
- 4 months ago - Fennec Pharmaceuticals Inc. (FENC) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Fennec Pharmaceuticals Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Business Update - GlobeNewsWire
- 5 months ago - Fennec Pharmaceuticals to Report Full Year and Fourth Quarter 2024 Financial Results on March 10, 2025 - GlobeNewsWire
- 5 months ago - Fennec Pharmaceuticals Announces Commercial Launch of PEDMARQSI® In Germany - GlobeNewsWire
- 7 months ago - Fennec Pharmaceuticals Announces Pedmarqsi® Positive Recommendation by NICE for the Prevention of Cisplatin-Induced Hearing Loss in England and Wales - GlobeNewsWire